News
27m
Asianet Newsable on MSNPfizer In Spotlight As FDA Reportedly Mulls Withdrawing Authorization For COVID-19 Vaccine For Kids Under 5: Retail Says Stock Is UndervaluedAccording to a Bloomberg report, Pfizer has requested that the approval stay in place through the coming fall season.
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
The Food and Drug Administration is considering revoking Pfizer Inc.’s authorization to sell its Covid vaccine for children under the age of 5, a move that would leave healthy kids with no available ...
This fall, it may not be possible for many parents to have a healthy child younger than age 5 immunized against COVID.
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.
Those who invested in Pfizer three years ago and hung on are not thrilled. They would have done much better with a simple S&P ...
Pfizer › Pfizer (NYSE: PFE) has been a terrible investment over the past three years. Revenue and earnings have generally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results